Anti-Müllerian hormone (AMH) is both a gonadal hormone and a putative paracrine regulator of neurons, the uterus, and the placenta. A mouse line with neuronal expression of AMH (Thy1.2-AMH) was generated to examine the role of paracrine AMH in the brain. The mice had normal behavior, but unexpectantly AMH was present in the circulation of the transgenic mice. Thy1.2-AMH Tg/0 studs sired pups with a normal frequency, when mated with wild-type dams. In stark contrast, Thy1.2-AMH Tg/0 dams rarely gave birth, with evidence of spontaneous midgestational abortion. This leads to the hypothesis that AMH influences the capacity of dams to carry concepti to term. This hypothesis was tested by mating AMH-deficient (Amh −/− ), Thy1.2-AMH Tg/0 , and wildtype dams when 49-, 80-, and 111 days old, using proven wild-type studs. The litter sizes from the first two matings and the number of fetuses present on the 10th day of gestation of the third mating were recorded. Thy1.2-AMH Tg/0 dams carried near normal numbers of midterm fetuses, but typically produced no pups, indicating that extensive late resorption of fetuses was occurring. Amh −/− dams exhibited a lesser reduction in litter size than the Thy1.2-AMH Tg/0 dams, with no evidence of enhanced loss of fetuses. In conclusion, this study provides the first evidence that high AMH levels can cause a miscarriage phenotype and that the absence of AMH affects reproductive output.
Introduction
Anti-Müllerian hormone (AMH) is a sexually dimorphic gonadal hormone [1, 2] , which is also synthesized by various nongonadal cells, including some mature neurons [3] [4] [5] , the uterus [6] , and the placenta [7] . Circulating AMH is entirely derived from the gonads [8, 9] , suggesting that the nongonadal sources of AMH act exclusively as paracrine regulators.
In mature females, both the endocrine and paracrine sources of AMH are linked to reproduction. Circulating ovarian AMH exhibits minimal variation during the ovarian cycle [10] , but declines acutely during the second and third trimester of pregnancy [11] [12] [13] , and chronically with age, in parallel with the decline in the pool of growing ovarian follicles [14] . AMH slows reproductive senescence in mice [15] , and modulates the influence of follicle-stimulating hormone (FSH) on granulosa cells [16] . However, the physiological actions of AMH may extend to other reproductive organs, as the AMH-specific receptor (AMHR2) is expressed in the mammary gland [17] , uterus [6, 18] , and placenta [7] . Speculatively, the ageand/or pregnancy-related decline in circulating AMH may modulate the transfer of resources from the mother to her offspring. Equally, the uterus and placenta synthesize AMH [6, 7] , raising the possibility that the uterine and placental receptors are predominantly or exclusively activated by locally produced (paracrine) AMH.
Transgenic mice with neuron-specific expression of human AMH (hAMH) were generated to study the role of paracrine AMH in the mature brain. The receptor-binding region of hAMH is 93% homologous to the murine protein and activates murine AMH receptors in multiple experimental systems [19] [20] [21] . The Thy1.2 promoter was used to delay the expression of the transgene until neurons had matured [22] , thus mimicking the normal developmental onset of neuronal AMH expression, and avoiding the virilizing effect of AMH on the developing nervous system [23] [24] [25] . We report here that the Thy1. 2 
-AMH
Tg/0 mice contain transgenic hAMH in their circulation and exhibit a high rate of midterm loss of embryos.
Materials and methods

Thy1.2-AMH mice
A cDNA clone containing the full-length Homo sapiens AMH mRNA was purchased from InVitrogen/Life Technologies (MGC:54308; IMAGE:5168299; Unigene Cluster ID: Hs.112432; Carlsbad, CA, USA). The AMH gene was cloned into the mouse thymus antigen 1.2 (Thy1.2) expression cassette [22] The mice were terminally anaesthetized with ketamine (225 mg/kg, Phoenix Pharm) and Domitor (3 mg/kg, Medetomidine, Pfizer Animal Health), after which blood was drawn by cardiac puncture and clotted at room temperature for 1 h. The serum was aliquoted and snap-frozen in liquid nitrogen for storage at -80 • C. The transgenic hAMH levels were assayed using a method that does not detect endogenous murine AMH [28] . Briefly, the samples were diluted 1:24 and were assayed using the PicoAMH ELISA (Cat# AL-124-I; Ansh Labs) as per the manufacturer's procedure, with the exception that the antibody-biotin conjugate was replaced with the antibody-biotin conjugate (100 μL) from the AMH Gen II ELISA kit (Cat# A79765; BeckmanCoulter). The picoAMH ELISA capture antibody produces high sensitivity and the Gen II detection antibody circumvents the variable ability of the picoAMH detection antibody to recognize different recombinant hAMH preparations.
Quantitative reverse transcriptase-PCR detection of human anti-Müllerian hormone expression
Tissue specificity
The adrenal glands, brain, heart, kidney, liver, lung, skeletal muscle, and the uterus from four Thy1.2-AMH Tg/0 were rapidly dissected, snap-frozen in liquid nitrogen, after which the mRNA was extracted and cDNAs generated as previously described [29] . The primers were designed to amplify the hAMH transgene but not murine Amh cDNA, with cDNA from the brains of wildtype mice used to verify primer specificity (F 5 AGGAAGTGAC-CTGGGAGCAACA 3 , R 5 AGCCCAGCCCTCGTCACAGTGA 3 ). Hypoxanthine-guanine phosphoribosyltransferase (Hprt) expression (F 5 CTGGTGAAAAGGACC-TCTCG 3 , R 5 TGAAG-TACTCATTATAGTCAAGGGCA 3 ) was used to normalize data for mRNA abundance.
Temporal specificity A portion of the brains from 0-, 5-, 15-, 22-, 30-, 42-, and 53-day-old Thy1.2-AMH Tg/0 mice were processed as described in the previous paragraph, with the exception that glyceraldehyde 3-phosphate deydrogenase (Gapdh) expression (F 5 TCTTCACCACCATGGAGAAG 3 , 5 ACCAAAGTTGTCAT GGAT-GAC 3 ) was used to normalize the data for mRNA abundance.
Localization of human anti-Müllerian hormone and endogenous anti-Müllerian hormone protein
The localization of the transgenic hAMH protein was examined by immunohistochemistry using perfusion-fixed tissues, as previously described [25] . wild-type stud for mating over a 9-day period. The dams were transferred to the stud's cage, with each stud only having one partner at any one time. Eleven wild-type studs were used (AMH +/+ mice or Thy1.2-AMH 0/0 mice, derived from either of the congenic colonies),
and were mated at random with the dams. The dams were mated when aged 49-, 80-and 111 days old. All pups derived from the first two matings were culled at birth, and the litter sizes recorded. During the third mating, the dams were examined daily for the presence of a postcoital plug, and euthanized 10 days after the detection of the plug. The number of fetuses being carried was recorded.
Statistical analysis
The difference in the frequency of births within 50 days of mating ( Figure 4 ) were examined using a Binomial Test, with an expected frequency of 1 (frequency observed in Amh +/+ dams). The influence of genotype on the frequency of dams with no pups or fetuses was examined using a Pearson's Chi squared test, with pair-wise comparison using a Fischer exact test when a statistically significant effect of genotype was observed (P < 0.05) ( Figure 5 ). The differences in the sizes of litters generated by Thy1.2-AMH Tg/0 studs and dams were examined using a one-way ANOVA. When three groups of dams were compared, a two-way ANOVA was used: pair-wise comparisons of genotype were made using one-way ANOVA when the two-way ANOVA was significant for genotype. The litter size data were also analyzed using a three-way ANOVA approach to take parity into account; the three factors were genotype, nulliparous (yes/no), and offspring stage (i.e., pup count for litter 1 and 2 or E10 embryo for litter 3). IBM SPSS Statistics v21 and Prism 7 (GraphPad Software Inc) were used for the statistical calculations.
Results
Only two of the 25 founder mice contained the transgene: both were female. One founder failed to give birth after 139 days of mating, despite the stud being replaced after 60 days. The other founder gave birth to a litter of seven pups 34 days after being paired with a stud, mice, with the notable exception of the thalamus and hypothalamus ( Figure 2 ; Supplemental Information Files 2 and 3). In the cerebral cortex, for example, the neurons in the multiform (VI) and internal pyramidal cell (V) layers were strongly stained by the anti-AMH antibody, as were most but not all of the external pyramidal cells. There was, however, minimal or no immunoreactivity in the internal (II) and external granular (IV) layers. The transgene was also detected in a minority of pituitary cells (Supplemental File 3). The mean levels of hAMH mRNA in brain were 8.5% of housekeeping gene (Hprt) mRNA levels but were less than 0.5% in adrenal glands, heart, kidney, liver, skeletal muscle, and uterus. Slightly higher levels were observed in the lung (0.9% of Hprt mRNA levels), which is consistent with prior reports of Thy1.2 promoter-driven transgene expression [22] . Unexpectedly, serum from adult (44-98 day old) Thy1.2-AMH Tg/0 mice contained 1.12 ± 0.14 nmol/L (n = 14)
of hAMH. The serum of the wild-type littermates contained undetectable levels of hAMH, as expected (<0.02 pM, n = 16). AMH in the blood is a mixture of uncleaved proAMH and AMHR2-receptorcompetent AMH N,C : the molecular forms of the hAMH in the blood of theThy1.2-AMH Tg/0 mice mirrors that of AMH in human serum [28] . (Figure 3 ). At most stages of follicle development, similar levels of AMH expression were Figure 4A ). The litter size was also markedly smaller when the transgene was carried by the dam rather than the stud ( Figure 4B) , independent of the number of back crosses. The frequency of Thy1.2-AMH Tg/0 pups in litters that were genotyped was close to the Mendelian ratio (49.1%, n = 242), indicating that Thy1.2-AMH Tg/0 fetuses were not selectively lost in utero. The time between the stud-dam pairing and birth was independent of which sex carried the transgene ( Figure 4C ). 
Thy1.2-AMH
Tg/0 dams exhibited copulatory plugs, indicating that mating had occurred and four out of six were carrying fetuses on day 10 of the third mating ( Figure 5 ). Despite the severely reduced capacity of Thy1.2-AMH Tg/0 dams to produce live offspring, there was no significant effect of genotype across the three groups in the frequency of pregnancy on embryonic day 10. When the matings that resulted in pups or fetuses were analyzed, the Amh −/− dams on average carried fewer offspring (pups or fetuses) than the wild-type dams, by between 1.1 and 1.4 offspring per mating. The effect of Amh genotype was strongly significant when the three matings were examined as a group (P = 0.001), after correction for the influence of parity and whether the dam was examined at E10 or at birth (Figure 6 ) 1 . The influence of Amh genotype was also strongly evident if the analysis was restricted to the 1 The first litter of a dam tends to be smaller, with litters 2 and 3 being of similar size [30, 31] . The number of fetuses at E10 also tends to be larger than the number of pups born, as dams resorb a portion of their fetuses after E10 [30, 32] . Both of these phenomena are first two matings, which were examined at birth (P = 0.002, Fig 6) . The low frequency of detection of offspring precluded any statistical examination of the litter size of the Thy1.2-AMH Tg/0 dams. present in the main Amh colony: consequently, there was an a priori expectation that the three matings would be subtly different. This can be most simply controlled for by including mating number in the ANOVA. When this is done, the P value for Amh genotype was P < 0.0005. The dams did not invariably give birth after each of the first two matings (Figure 5 ), and the dams in the second and third matings were therefore heterogenous with respect to parity. Consequently, the differences between the matings were controlled for by using two binary variables (Nulliparous: yes/no and Stage: E10/birth). The inclusion of the additional binary variables decreases the inherent statistical power, but more accurately reflects the underlying biology. However, the observed power (0.92 at α = 0.05) and P value (0.001) for the effect of Amh genotype indicates that the sample size was sufficiently large to use this approach. 
Discussion
The regulation of litter size is complex, both with respect to cause and mechanism. Nulliparous and older dams tend to have smaller litters, but with variation between dams, even in inbred colonies [30, 31] . Environmental influences that alter energy balance also have large effects on litter size, which can involve trade-offs between the number and size of pups [31, 33] . Mechanistically, litter size is determined by multiple factors, including the number of oocytes released, the rate of implantation, and by resorption of concepti during either the embryonic or fetal stages [30, 32] . AMH influences the rate of depletion of ovarian follicles [15] , which putatively influences when a female experiences age-related difficulty to conceive. The reproductive output of the Thy1.2-AMH Tg/0 and Amh −/− dams raises the possibility that AMH may also be part of the molecular mechanism(s) that enable dams to adapt their reproductive output to their current circumstances. dams carried too many fetuses at midgestation for it to be a major mechanism. The influence of the transgenic AMH in the current study was of similar magnitude in the nulliparous and multiparous dams, suggesting that AMH is not an essential part of the mechanism that diminishes the size of litters of nulliparous dams.
Litter size of Amh −mh dams
Mice that lacked the Amh gene also had smaller litters. The magnitude of the effect was, however, smaller than that observed in the Thy1.2-AMH Tg/0 dams, and there was no overt loss of fetuses after midgestation. This suggests that the absence and the overexpression of AMH may be affecting litter size via different mechanisms. Circulating AMH levels reflect the number of growing ovarian follicles, and decline to zero during ovarian ageing [34] . The phenotype of the young Amh −/− dams thus leads to the hypotheses that low levels of AMH within the ovary and/or the circulation are causal determinants of age-related decline in reproductive output. The first litters of the Amh −/− dams were smaller on average than their second litters, which adds to the evidence that the lower reproductive capacity of nulliparous dams is independent of AMH.
Possible sites of anti-Müllerian hormone action
AMH is potentially a complex regulator of the reproductive capacity of females, with multiple sites of action. AMH inhibits the primordial to primary follicle transition in the ovary [15] and reduces granulosa cell sensitivity to FSH in developing follicles [16] . The number of oocytes progressing to ovulation in mice is thought to be independent of AMH. However, the studies that underpin this view had group sizes [15, 35] that are insufficient to detect an average reduction in the ovulation rate of between one and two oocytes. It is therefore possible that the smaller litter size of Amh −/− dams is due to a reduction in the average number of concepti generated at mating. Influence of a null mutation of Amh on reproductive output by dams. The experiment is as described in Figure 5 . Dams were only included in the analysis if birth occurred (pairing 1 and 2) or if fetuses were detected at E10 from the third mating. The data is the mean plus the standard error of the mean, with the number of mice indicated on the bar. * There was a significant effect of genotype (P = 0.001) in a three-way ANOVA, controlling for whether the dam was nulliparous and whether fetuses or pups were examined. 1 # There was a significant effect of genotype (P = 0.002) and parity (P = 0.008), with no significant genotype-by-parity interaction (P = 0.65) (two-way ANOVA). When the wild-type and Amh −/− dams were compared separately for each mating, the P values were as follows: first P = 0.030; second P = 0.035, third P = 0.058 (one-way ANOVA).
Equally, the antecedents of spontaneous abortion could involve the oocyte quality, with AMH potentially affecting the fitness of oocytes through its action on granulosa cells. [36] . AMHR2 is expressed by the oviduct (Pankhurst, unpublished observations) , the uterus [6, 37] , and by the placenta [7] . These AMH receptors are in an appropriate location to regulate implantation and the maturation of the maternal-fetal interface, but the physiological functions of these receptors has yet to be investigated. It is also unknown whether the placental and uterine AMH receptors are exclusively activated by locally produced AMH, AMH released from follicular fluids at ovulation, by circulating AMH or combinations of these sources.
Successful pregnancy also requires changes in various neural networks and the pituitary. AMH is produced within the brain, and AMHR2 is broadly expressed by neurons [23] . The recent discovery that hypothalamic AMHR2 expression modulates gonadotropinreleasing hormone secretion [38] highlights the possibility that the physiological control of AMH levels within the brain and pituitary underpins successful pregnancy.
Permissive versus instructive mechanisms
When a trait is generated by a simple dose-response curve, no expression and overexpression are at opposite ends of a spectrum. 
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